MENU
+Compare
AMGN
Stock ticker: NASDAQ
AS OF
Dec 26, 10:36 AM (EDT)
Price
$332.98
Change
-$0.98 (-0.29%)
Capitalization
179.83B

AMGN Amgen Forecast, Technical & Fundamental Analysis

Amgen is a leader in biotechnology-based human therapeutics... Show more

Industry: #Biotechnology
AMGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for AMGN with price predictions
Dec 24, 2025

AMGN in upward trend: price may jump up because it broke its lower Bollinger Band on December 05, 2025

AMGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 38 cases where AMGN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 22, 2025. You may want to consider a long position or call options on AMGN as a result. In of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AMGN just turned positive on December 24, 2025. Looking at past instances where AMGN's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMGN advanced for three days, in of 309 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 231 cases where AMGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for AMGN moved out of overbought territory on December 01, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (18.692) is normal, around the industry mean (9.054). P/E Ratio (25.828) is within average values for comparable stocks, (24.434). Projected Growth (PEG Ratio) (1.050) is also within normal values, averaging (2.056). Dividend Yield (0.029) settles around the average of (0.026) among similar stocks. P/S Ratio (5.030) is also within normal values, averaging (3.759).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AMGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

AMGN is expected to report earnings to fall 16.13% to $4.73 per share on February 03

Amgen AMGN Stock Earnings Reports
Q4'25
Est.
$4.73
Q3'25
Beat
by $0.60
Q2'25
Beat
by $0.76
Q1'25
Beat
by $0.61
Q4'24
Beat
by $0.27
The last earnings report on November 04 showed earnings per share of $5.64, beating the estimate of $5.04. With 833.66K shares outstanding, the current market capitalization sits at 179.83B.
A.I.Advisor
published Dividends

AMGN paid dividends on September 12, 2025

Amgen AMGN Stock Dividends
А dividend of $2.38 per share was paid with a record date of September 12, 2025, and an ex-dividend date of August 22, 2025. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of human therapeutic products based on cellular biology

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Biotechnology
Address
One Amgen Center Drive
Phone
+1 805 447-1000
Employees
26700
Web
https://www.amgen.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CGDV44.220.12
+0.27%
Capital Group Dividend Value ETF
BUFZ26.580.03
+0.11%
FT Vest Laddered Moderate Bffr ETF
AMDY38.380.04
+0.10%
YieldMax AMD Option Income Strategy ETF
XRLV54.08N/A
N/A
Invesco S&P 500® ex-Rate Snsv LowVol ETF
CPSO27.07N/A
N/A
Calamos S&P 500 Str Alt Prt ETF-Oct

AMGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
+0.75%
PFE - AMGN
63%
Loosely correlated
+0.60%
BMY - AMGN
57%
Loosely correlated
+0.79%
ABBV - AMGN
56%
Loosely correlated
+0.48%
NVS - AMGN
55%
Loosely correlated
-0.18%
MRK - AMGN
55%
Loosely correlated
+1.34%
More